OLR1 and breast cancer: In particular, in HER-2-enriched breast cancer, we noticed a strong LOX-1 overexpression as compared with other phenotypes, suggesting a possible involvement of FASN in modulating proliferative rate of this breast cancer cells suggesting a potential connection of LOX-1 in FASN-HER-2 axis.